483
Bushu Pharmaceuticals Ltd.Bushu Pharmaceuticals Ltd. – FDA 483, Dec 2, 2022
Record Details
An FDA inspection of Bushu Pharmaceuticals Ltd. in Kawagoe, Japan, revealed significant deficiencies across its operations. The firm failed to adequately document and follow quality control unit procedures for complaints, deviations, and laboratory investigations. Additionally, established laboratory test procedures and facility control systems were found to be deficient, leading to concerns about data integrity, contamination prevention, and proper material segregation.
View Company Profile
ID · b6765841-7334-4c55-a03f-48209c769b8e
Other documents for Bushu Pharmaceuticals Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.